This popular pocket book has been updated and expanded throughout, providing a concise view of diagnostic haematology, in a convenient and practical format. A Beginner's Guide to Blood Cells is an ideal for; Trainee laboratory technicians and scientists Students studying the physiology or pathology of the blood Those preparing for haematology examinations Why Buy This Book? Unique pocket guide, written by Barbara Bain – a world-renowned expert in the field of blood morphology Outlines the basics of diagnostic haematology Includes an invaluable self-assessment section NEW EDITION – now includes more information on clinical aspects and further tests
Edited by an orthopaedic surgeon and a haematologist who are leading specialists in the treatment of haemophilia, Inhibitors in Patients with Haemophilia reviews the different haemostatic products and protocols for the control of bleeding and surgery in haemophilic patients with inhibitors. The book draws together in a single volume all of the clinical issues involved in the treatment of inhibitors from numerous specialists worldwide. It will be an invaluable resource for all those treating inhibitors in people with haemophilia.
The Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world.
The Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world.
The Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world.
The Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world.
This book is written with both degree and diploma student midwives in mind. It is split into two sections, each alphabetical. The first section contains some of the language of midwifery: terms, abbreviations and definitions. The second section contains common conditions, procedures, emergency situations, and supporting information. Each topic includes further factors that involve recognition, prevention, and actions to take in an emergency situation that may be in the form of flow/action charts. The procedures that are included have an overview of the 'how to', (frequently including the preparation needed); and the 'why', supported by research or evidence, and Midwives’ rules and standards (NMC 2004b) and The NMC code of professional conduct: standards for conduct, performance and ethics (NMC 2004a). The references used provide useful evidence to support practice. Finally, the supporting information is varied and ranges from details about Government and international initiatives to available support groups and useful websites.
This book is the British Medical Association’s statement on the ethics related to care of the elderly, written and reviewed by a panel of renowned medical ethicists. As such it is an authoritative and considered reference, written in an accessible, non jargon so as to be useful for anyone charged with looking after the elderly. The book includes useful case examples so that it can be used by a range of health professionals and carers who need to know the law and ethics of looking after older people. The authors focus on practical issues such as helping older people stick to their treatment regimes, the sort of information they should be given to give valid consent, and their rights to confidentiality, as well as discussion about where they want to end their lives when it comes to that point.
Heart failure is effectively a disease of older people. Eighty percent of patients are over 65 years old, and the majority of these are over 75. This figure is likely to increase significantly in the next two decades. The prognosis is worse than that of most cancers and heart failure is the commonest reason for hospital admission in the over 65s. The problems associated with treating heart failure in older patients are more diverse and complex than in those who are younger. The diagnosis in older patients is easily overlooked and as they were excluded from most heart failure treatment trials there has been a reluctance to treat them optimally (fewer than 20% are prescribed conventional medicines). They have multiple co-morbidities which are poorly managed, they are repeatedly hospitalised, and suffer social isolation. These important age-related treatment and management problems have been largely ignored and this book aims to redress the balance. It provides a concise, comprehensive account of the epidemiology, pathogenesis, diagnosis, treatment, management and end-of-life care of elderly patients with heart failure, based on published studies. A Practical Guide to Heart Failure in Older People is essential reading for geriatricians, cardiologists, general hospital physicians, family practitioners and specialist nurses. • Specifically addresses the particular needs of the elderly, a largely ignored group who constitute the majority of patients with heart failure • Presents a concise yet comprehensive account of the evidence relating to the diagnosis, treatment and management of heart failure in this population • Improves awareness of the various roles within the management team
According to the WHO, 170 million people, or 3% of the world's population, are infected with Hepatitis C and at risk of developing liver cirrhosis and/or liver cancer. 3-4 million people each year are newly diagnosed carriers of the virus. Advanced Therapy for Hepatitis C Infection provides you with expert guidance from the world’s leading hepatologists on the very latest treatment options for patients with the HCV virus. Focusing mainly on the efficacy and clinical use of antiviral therapies, key topics include: Treatment of recurrent hepatitis C following liver transplantation Antivirals in Cirrhosis and Portal Hypertension HIV and Hepatitis C co-infection Cytopenias: how they limit therapy and potential correction The problem of insulin resistance and its effect on therapy Antivirals in Acute Hepatitis C In addition, it fully covers the foundations for understanding antiviral therapies in HCV, such as the complex pharmacology and mechanisms of antiviral drugs. Finally, a chapter on New Horizons: Interleukin 28 and direct-acting antiviral therapy for HCV, offers you a glimpse into the future possibilities for HCV therapy. Edited by a team of outstanding international reputation, Advanced Therapy for Hepatitis C Infection is an essential tool for all hepatologists and gastroenterologists involved in the management of patients with Hepatitis C.